Market Overview

Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec

Share:

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that all proposals necessary for St. Jude Medical, Inc.'s acquisition of Thoratec Corporation were approved by Thoratec Corporation's shareholders at its shareholder meeting held today.

As previously announced, on July 21, 2015, Thoratec and St. Jude Medical entered into a definitive agreement by which St. Jude Medical will acquire Thoratec. Under the terms of the transaction, Thoratec shareholders will receive $63.50 in cash for each Thoratec share.

Thoratec expects that the transaction will close on October 8, 2015.

Posted-In: News Press Releases

 

Related Articles (THOR)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Aegerion Pharmaceuticals Grants 56.923K Stock Options Under Inducement Program, Exercise Price Of $13.19

Deutsche Bank Charge Tied to Impact of Higher Regulatory Capital Requirements, Expected To Log $5.8B Charge